Evidence map›Paper›PMID 31009792›Full record

Observational studyClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2020

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.

Suk Seo, Michael J Silverberg, Leo B Hurley, Joanna Ready, Varun Saxena, David Witt, C Bradley Hare, Jamila H Champsi, Daniel G Korn, Mary Patricia Pauly and 3 more

Abstract readLetterObservational Study
In one paragraph

Observational study in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Potential Impact of Frequent Testing for Hepatitis C Virus Among People Who Inject Drugs Toward Hepatitis C Elimination in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Hepatitis C virus outbreak at a pain clinic in Los Angeles.Infection control and hospital epidemiology · 2024
    Article
  16. Incidence of Etiology-specific Hepatocellular Carcinoma: Diverging Trends and Significant Heterogeneity by Race and Ethnicity.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  17. Article
  18. Article
  19. Universal screening for hepatitis C - in for a penny, in for a pound.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Suk SeoKaiser Permanente Antioch Medical Center, Antioch, California; Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California. Electronic address: suk.i.seo@kp.org.
Michael J SilverbergDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Leo B HurleyDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Joanna ReadyKaiser Permanente Santa Clara Medical Center, Santa Clara, California.
Varun SaxenaKaiser Permanente South San Francisco Medical Center, South San Francisco, California.
David WittKaiser Permanente San Rafael Medical Center, San Rafael, California.
C Bradley HareKaiser Permanente San Francisco Medical Center, San Francisco, California.
Jamila H ChampsiKaiser Permanente South San Francisco Medical Center, South San Francisco, California.
Daniel G KornKaiser Permanente Oakland Medical Center, Oakland, California.
Mary Patricia PaulyKaiser Permanente Sacramento Medical Center, Sacramento, California.
Scott ChamberlandKaiser Permanente Northern California, Regional Pharmacy, Oakland, California.
Jennifer B LaiKaiser Permanente San Rafael Medical Center, San Rafael, California.
Julia L MarcusHarvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

Funding

Optimizing Care for HIV/HCV-Coinfected Patients in the New HCV Treatment EraK01AI122853 · NIAID · KAISER FOUNDATION RESEARCH INSTITUTE · PI MARCUS, JULIA L. · 2016 to 2020
$655k
NIAID NIH HHS K01 AI122853
6 · The paper itself

Abstract

Strategic planning for hepatitis C virus (HCV) screening and treatment requires up-to-date information on the prevalence of HCV spontaneous clearance. Published estimates of HCV spontaneous clearance range from 15% to 60%.

Indexed as

HepacivirusHepatitis CHepatitis C AntibodiesHumansPrevalenceViremiaHepatitis C Antibodies

Identifiers

PMID31009792
PMCPMC6801008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.